Reflecting on Capstan’s Journey & Reimagining the Future of In Vivo Therapies

• Reviewing Capstan’s clinical milestones and acquisition to uncover lessons shaping next-generation strategies
• Highlighting pivotal breakthroughs and remaining challenges to accelerate progress in in vivo gene editing
• Exploring future opportunities and emerging technologies to drive innovation and maximize patient impact

Speakers:

Haig Aghajanian

Adjunct Assistant Professor of Medicine

University of Pennsylvania